Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study

OBJECTIVES: To investigate the safety and effectiveness of mepolizumab (MPZ), an anti-interleukin-5 antibody, as remission induction therapy for severe eosinophilic granulomatosis with polyangiitis (EGPA). METHODS: The clinical courses of patients with severe EGPA over 6 months were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Masanobu, Miyagawa, Ippei, Aritomi, Takafumi, Kimura, Koichi, Iwata, Shigeru, Hanami, Kentaro, Fukuyo, Syunsuke, Kubo, Satoshi, Miyazaki, Yusuke, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241238/
https://www.ncbi.nlm.nih.gov/pubmed/35768825
http://dx.doi.org/10.1186/s13075-022-02845-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241238/
https://www.ncbi.nlm.nih.gov/pubmed/35768825
http://dx.doi.org/10.1186/s13075-022-02845-3

Ejemplares similares